STOCK TITAN

Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Ginkgo Bioworks (NYSE: DNA), a leader in cell programming and biosecurity, has scheduled its Q1 2025 earnings presentation for Tuesday, May 6, 2025, at 5:30 p.m. ET. The company will review its business performance for the quarter ended March 31, 2025.

The presentation will be accessible through Ginkgo's investor relations website at investors.ginkgobioworks.com, with a replay option available. Stakeholders can submit questions beforehand via:

  • X (formerly Twitter) using @Ginkgo and #GinkgoResults
  • Email at investors@ginkgobioworks.com

Ginkgo Bioworks (NYSE: DNA), leader nella programmazione cellulare e nella biosicurezza, ha programmato la sua presentazione dei risultati del primo trimestre 2025 per martedì 6 maggio 2025, alle 17:30 ET. L'azienda esaminerà le performance operative relative al trimestre terminato il 31 marzo 2025.

La presentazione sarà disponibile sul sito web per gli investitori di Ginkgo all'indirizzo investors.ginkgobioworks.com, con la possibilità di riascoltarla in differita. Gli stakeholder potranno inviare domande in anticipo tramite:

  • X (ex Twitter) usando @Ginkgo e l'hashtag #GinkgoResults
  • Email all'indirizzo investors@ginkgobioworks.com

Ginkgo Bioworks (NYSE: DNA), líder en programación celular y bioseguridad, ha programado su presentación de resultados del primer trimestre de 2025 para el martes 6 de mayo de 2025, a las 5:30 p.m. ET. La compañía revisará su desempeño comercial correspondiente al trimestre finalizado el 31 de marzo de 2025.

La presentación estará disponible a través del sitio web de relaciones con inversores de Ginkgo en investors.ginkgobioworks.com, con opción de reproducción. Los interesados podrán enviar preguntas con anticipación mediante:

  • X (anteriormente Twitter) usando @Ginkgo y #GinkgoResults
  • Correo electrónico a investors@ginkgobioworks.com

Ginkgo Bioworks (NYSE: DNA), 세포 프로그래밍 및 생물 보안 분야의 선두주자가 2025년 5월 6일 화요일 오후 5시 30분(동부시간)에 2025년 1분기 실적 발표를 예정하고 있습니다. 회사는 2025년 3월 31일로 종료된 분기의 사업 실적을 검토할 예정입니다.

발표는 Ginkgo 투자자 관계 웹사이트 investors.ginkgobioworks.com을 통해 시청할 수 있으며, 재생 옵션도 제공됩니다. 이해관계자들은 사전에 다음을 통해 질문을 제출할 수 있습니다:

  • X(구 트위터)에서 @Ginkgo 및 #GinkgoResults 사용
  • 이메일 investors@ginkgobioworks.com

Ginkgo Bioworks (NYSE : DNA), leader dans la programmation cellulaire et la biosécurité, a programmé sa présentation des résultats du premier trimestre 2025 pour le mardi 6 mai 2025 à 17h30 (heure de l'Est). La société présentera ses performances commerciales pour le trimestre clos le 31 mars 2025.

La présentation sera accessible via le site web des relations investisseurs de Ginkgo à l'adresse investors.ginkgobioworks.com, avec une option de replay disponible. Les parties prenantes peuvent soumettre leurs questions à l'avance via :

  • X (anciennement Twitter) en utilisant @Ginkgo et #GinkgoResults
  • Par email à investors@ginkgobioworks.com

Ginkgo Bioworks (NYSE: DNA), ein führendes Unternehmen im Bereich Zellprogrammierung und Biosecurity, hat seine Gewinnpräsentation für das erste Quartal 2025 für Dienstag, den 6. Mai 2025, um 17:30 Uhr ET geplant. Das Unternehmen wird die Geschäftsergebnisse für das Quartal zum 31. März 2025 vorstellen.

Die Präsentation wird über die Investor-Relations-Website von Ginkgo unter investors.ginkgobioworks.com zugänglich sein, mit einer Wiedergabeoption. Interessierte können im Voraus Fragen einreichen über:

  • X (ehemals Twitter) mit @Ginkgo und #GinkgoResults
  • E-Mail an investors@ginkgobioworks.com
Positive
  • None.
Negative
  • None.

Presentation and Q&A session scheduled for post-market on Tuesday, May 6, 2025

BOSTON, April 29, 2025 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the first quarter ended March 31, 2025, on Tuesday, May 6, 2025, beginning at 5:30 p.m. ET.

The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.

To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.

About Ginkgo Bioworks

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats.  For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com    

MEDIA CONTACT:

press@ginkgobioworks.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-first-quarter-2025-results-presentation-302441429.html

SOURCE Ginkgo Bioworks

FAQ

When will Ginkgo Bioworks (DNA) release Q1 2025 earnings?

Ginkgo Bioworks (DNA) will release its Q1 2025 earnings on Tuesday, May 6, 2025, at 5:30 p.m. ET, after market close.

How can investors participate in Ginkgo Bioworks Q1 2025 earnings call?

Investors can access the webcast through Ginkgo's investor relations website at investors.ginkgobioworks.com. Questions can be submitted via X (using #GinkgoResults) or by emailing investors@ginkgobioworks.com.

What period does Ginkgo Bioworks (DNA) Q1 2025 earnings cover?

The earnings presentation will cover Ginkgo Bioworks' financial performance for the first quarter ended March 31, 2025.

Will there be a replay available for Ginkgo Bioworks Q1 2025 earnings call?

Yes, a replay of the earnings presentation and Q&A session will be made available on Ginkgo's investor relations website.

How can investors submit questions for Ginkgo Bioworks Q1 2025 earnings?

Investors can submit questions by either posting on X with the hashtag #GinkgoResults or by sending an email to investors@ginkgobioworks.com.
Ginkgo Bioworks Holdings Inc

NYSE:DNA

DNA Rankings

DNA Latest News

DNA Stock Data

425.97M
54.26M
6.6%
79.85%
15.62%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
BOSTON